Article Information
History
- January 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tigist W. Leulseged, (MD, MPH)1,*,
- Ishmael S. Hassen, (MD)1,
- Birhanu T. Ayele, (MSc, PhD)1,□,
- Yakob G. Tsegay, (BSc, MSc)2,
- Daniel S. Abebe, (MD)2,
- Mesay G. Edo, (MD)2,
- Endalkachew H. Maru, (MD)2,
- Wuletaw C. Zewde, (MD)2,
- Lydia K. Naylor, (MD)3,
- Dejene F. Semane, (MD)3,
- Menayit T. Deresse, (MD)3 and
- Bereket B. Tezera, (MD)3
- 1-3Millennium COVID-19 Care Center, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
- ↵*Corresponding author: Tigist W. Leulseged, Research development office, Millennium COVID-19 Care Center, Addis Ababa, Ethiopia Department of Internal Medicine, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, Email address: tigdolly{at}gmail.com
Posted January 04, 2021.
Laboratory Biomarkers of COVID-19 Disease Severity and Outcome: Findings from a Developing Country
